ACTU
Actuate Therapeutics, Inc. Common stock
NASDAQ: ACTU · HEALTHCARE · BIOTECHNOLOGY
$2.88
-0.69% today
Updated 2026-04-29
Market cap
$68.29M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.06
Dividend yield
—
52W range
$2 – $12
Volume
0.1M
Actuate Therapeutics, Inc. Common stock (ACTU) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Operating cash flow | $-17.79M | $-21.63M | $-21.84M | $-19.21M |
| Capital expenditures | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation | — | — | — | — |
| Stock-based comp | $654066.00 | $423539.00 | $2.00M | $6.05M |
| Free cash flow | $-17.79M | $-21.63M | $-21.84M | $-19.21M |
| Investing cash flow | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Share repurchases | — | — | — | — |
| Debt repayment | — | — | — | — |
| Net change in cash | — | — | — | — |